Cargando…
Financing Drug Innovation in the US: Current Framework and Emerging Challenges
The current US drug innovation financing framework rests on the notion that a defined period of marketing exclusivity combined with the expectation of reimbursement for clinically valuable, cost-effective therapies, followed by vigorous price competition from generic drugs and biosimilars ensures a...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer International Publishing
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7247916/ https://www.ncbi.nlm.nih.gov/pubmed/32452010 http://dx.doi.org/10.1007/s40273-020-00926-2 |